Claire McCaskill actually said...

That would be a reasonable place for us to do the research about the average amount that is used.

McCaskill suggests focusing on joint replacements for opioid research.

01/18/2016

More Claire McCaskill Quotes

My only comment on the call is you sounded a little defensive on the price increase question.

Valeant has said that they have turned over a new leaf, that they have had a conversion on the road to Damascus.

Well, we are in trouble if you are---over the last year, with everything that has gone on in the company, if you are 78 percent over last ye...

I think it is misleading to act as if this is a problem with four drugs. This is the business model.